Skip to main content
. 2023 Feb 20;11(2):e005701. doi: 10.1136/jitc-2022-005701

Figure 4.

Figure 4

Prognosis of patients after hCART19 therapy. Event-free survival (EFS) (A) and overall survival (OS) (B) of complete remission (CR) patients in the three groups.